Clear Cell Adenocarcinoma — Trials

Clear Cell Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

362 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 150
Recruiting: 79
Ph III recruiting: 9
Growth YoY: −15.8%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 151–161 of 161 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05199272	A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies	active not recruiting	Phase 1 / Phase 2	141	23andMe, Inc.INDUSTRY	2	Nov 15, 2024	clinicaltrials
NCT06690697	Combination of Toripalimab and JS004 Therapy for ccRCC	recruiting	Phase 2	80	Fudan UniversityOTHER	1	Nov 15, 2024	clinicaltrials
NCT06519760